Back to Search
MARK BENYUNES, M.D.
M.D.
Medical Oncology Physician
NPI: 1538418298Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
MD00026459(WA)
Research & Publications (9)
Rituximab in combination with fludarabine chemotherapy in low-grade or follicular lymphoma.
PMID 15681517·J Clin Oncol·2005
3-trial
Recombinant human thrombopoietin augments mobilization of peripheral blood progenitor cells for autologous transplantation.
PMID 12813449·Biol Blood Marrow Transplant·2003
3-trial
Use of thrombopoietin in combination with chemotherapy and granulocyte colony-stimulating factor for peripheral blood progenitor cell mobilization.
PMID 12434950·Biol Blood Marrow Transplant·2002
3-trial
Rituximab in combination with CHOP or fludarabine in low-grade lymphoma.
PMID 11842387·Semin Oncol·2002
6-review
Purging of autologous peripheral-blood stem cells using CD34 selection does not improve overall or progression-free survival after high-dose chemotherapy for multiple myeloma: results of a multicenter randomized controlled trial.
PMID 11533101·J Clin Oncol·2001
3-trial
Recombinant human thrombopoietin (rhTPO) after autologous bone marrow transplantation: a phase I pharmacokinetic and pharmacodynamic study.
PMID 11277173·Bone Marrow Transplant·2001
3-trial
Optimizing the use of rituximab for treatment of B-cell non-Hodgkin's lymphoma: a benefit-risk update.
PMID 11226001·Semin Oncol·2000
6-review
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1 DNA WAY, MAILSTOP 444B
SOUTH SAN FRANCISCO, CA 94080 - Phone
- (650) 225-1628
Quick Facts
- NPI
- 1538418298
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 9
Are you this provider?
Claim Your Profile